0001213900-22-008940.txt : 20220223 0001213900-22-008940.hdr.sgml : 20220223 20220223161207 ACCESSION NUMBER: 0001213900-22-008940 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220218 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Masson-Hurlburt Elizabeth CENTRAL INDEX KEY: 0001735256 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34673 FILM NUMBER: 22663741 MAIL ADDRESS: STREET 1: 400 CONNELL DRIVE STREET 2: SUITE 5000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER NAME: FORMER CONFORMED NAME: Masson Elizabeth DATE OF NAME CHANGE: 20180322 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CorMedix Inc. CENTRAL INDEX KEY: 0001410098 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4200 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-9500 MAIL ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4200 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 4 1 doc4.xml PRIMARY DOCUMENT X0306 4 2022-02-18 false 0001410098 CorMedix Inc. CRMD 0001735256 Masson-Hurlburt Elizabeth C/O CORMEDIX INC. 300 CONNELL DRIVE, SUITE 4200 BERKELEY HEIGHTS NJ 07922 false true false false EVP, Head of Clinical Ops. Common Stock 8000.0000 D Stock Option (Right to Buy Common Stock) 4.0300 2022-02-18 4 A false 100000.0000 0.0000 A 2032-02-18 Common Stock 100000.0000 100000.0000 D Stock Option (Right to Buy Common Stock) 8.3200 2031-01-11 Common Stock 140000.0000 140000.0000 D Stock Option (Right to Buy Common Stock) 5.6300 2030-05-11 Common Stock 37500.0000 37500.0000 D Stock Option (Right to Buy Common Stock) 4.0800 2030-05-11 Common Stock 37500.0000 37500.0000 D Stock Option (Right to Buy Common Stock) 5.6300 2030-02-25 Common Stock 24764.0000 24764.0000 D Stock Option (Right to Buy Common Stock) 8.3000 2029-01-10 Common Stock 20880.0000 20880.0000 D Stock Option (Right to Buy Common Stock) 1.4500 2028-03-19 Common Stock 54000.0000 54000.0000 D These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones. These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. These options were granted on 1/10/2019. These options vest, subject to continued employment, as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones. These options include options to purchase 2,100 shares that are subject to vesting each on January 10, 2021 and January 10, 2022. The options vest as follows: 37,200 will vest over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vest on the achievement of certain milestones, subject to continued employment. These options were granted on 02/18/2022. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. /s/ Elizabeth Masson-Hurlburt 2022-02-23